Chiara Garulli

Chiara Garulli

Auto-generated profile, based on publicly available information

Chiara Garulli

Department of Bioscience and Biotechnology, University of Camerino, Camerino 62032, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
DPDaniela Pozzi
Daniela Pozzi
CMCristina Marchini
Cristina Marchini
FCFrancesco Cardarelli
Francesco Cardarelli
HAHeinz Amenitsch
Heinz Amenitsch
CGChiara Garulli
Chiara Garulli
GCGiulio Caracciolo
Giulio Caracciolo

1 August 2014 in Biochemical Pharmacology
Verified
Journal Article
Closed access
CKCristina Kalogris
Cristina Kalogris
CGChiara Garulli
Chiara Garulli
LPLucia Pietrella
Lucia Pietrella
VGValentina Gambini
Valentina Gambini
SPStefania Pucciarelli
Stefania Pucciarelli
AAAugusto Amici
Augusto Amici

1 September 2014 in Fitoterapia
Verified
Journal Article
Closed access
LQLuana Quassinti
Luana Quassinti
Filippo MaggiFilippo Maggi
Filippo Maggi
LBLuciano Barboni
Luciano Barboni
MRMassimo Ricciutelli
Massimo Ricciutelli
MCManuela Cortese
Manuela Cortese
MBMassimo Bramucci
Massimo Bramucci

1 February 2014 in Cellular Signalling
Verified
Journal Article
Closed access
CGChiara Garulli
Chiara Garulli
CKCristina Kalogris
Cristina Kalogris
LPLucia Pietrella
Lucia Pietrella
CBCaterina Bartolacci
Caterina Bartolacci
CACristina Andreani
Cristina Andreani
AAAugusto Amici
Augusto Amici

1 January 2013 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
CMCristina Marchini
Cristina Marchini
CKCristina Kalogris
Cristina Kalogris
CGChiara Garulli
Chiara Garulli
LPLucia Pietrella
Lucia Pietrella
FGFederico Gabrielli
Federico Gabrielli
AAAugusto Amici
Augusto Amici
The crucial role of HER2 in epithelial transformation and its selective overexpression on cancer tissues makes it an ideal target for cancer immunotherapies such as passive immunotherapy with Trastuzumab. There are, however, a number of concerns regarding the use of monoclonal antibodies which include resistance, repeated treatments, considerable costs, and side effects that make active immunotherapies against HER2 desirable alternative approaches. The efficacy of anti-HER2 DNA vaccination has been widely demonstrated in transgenic cancer-prone mice, which recapitulate several features of human breast cancers. Nonetheless, the rational design of a cancer vaccine able to trigger a long-lasting immunity, and thus prevent tumor recurrence in patients, would require the understanding of how tolerance and immunosuppression regulate antitumor immune responses and, at the same time, the identification of the most immunogenic portions of the target protein. We herein retrace the findings that led to our most promising DNA vaccines that, by encoding human/rat chimeric forms of HER2, are able to circumvent peripheral tolerance. Preclinical data obtained with these chimeric DNA vaccines have provided the rationale for their use in an ongoing Phase I clinical trial (EudraCT 2011-001104-34).

24 November 2008 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
SKStavroula Kapralou
Stavroula Kapralou
AFAttilio Fabbretti
Attilio Fabbretti
CGChiara Garulli
Chiara Garulli
RSRoberto Spurio
Roberto Spurio
Claudio GualerziClaudio Gualerzi
Claudio Gualerzi
CPCynthia L. Pon
Cynthia L. Pon
Bacterial translation initiation factor IF1 is homologous to archaeal aIF1A and eukaryal eIF1A, which form a complex with their homologous IF2-like factors (aIF5B and eIF5B respectively) during initiation of protein synthesis. A similar IF1–IF2 interaction is assumed to occur in all bacteria and supported by cross-linking data and stabilization of the 30S–IF2 interaction by IF1. Here we compare Escherichia coli IF1 with thermophilic factors from Bacillus stearothermophilus and Thermus thermophilus. All three IF1s are structurally similar and functionally interchangeable in vivo and in vitro. However, the thermophilic factors do not stimulate ribosomal binding of IF2ΔN, regardless of 30S subunits and IF2 origin. We conclude that an IF1–IF2 interaction is not universally conserved and is not essential for cell survival.